Literature DB >> 33753176

Comparative evaluation of HET-CAM and ICE methods for objective assessment of ocular irritation caused by selected pesticide products.

Péter Budai1, Éva Kormos2, István Buda2, Gergő Somody2, József Lehel3.   

Abstract

Eye irritation potency of pesticides (fungicides, herbicides, insecticides) was comparatively tested by HET-CAM and ICE method. Based on the results of the tests the statistical analysis of agreement between classification using individual methods was done by Goodman-Kruskal's rank correlation and determination (calculation) of Cohen's kappa coefficient. Statistical analysis of agreement between classification revealed significant correlation between results of in vivo and in HET-CAM assays (76%). There was no significant correlation between result of in vivo and in ICE methods (64%). Weakest correlation was found between the data from in vitro HET-CAM and ICE tests. The percentage of agreement between two in vitro data was 48%. They may be recommended as a part of a battery of tests to reduce experimentation on mammals and to limit or eliminate pain and injury inflicted on experimental animals. The HET-CAM test is a useful tool for studying in vivo the potential conjunctival irritation, while the ICE test can be used to study corneal irritant effects in detail.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Eye irritation; HET-CAM test; ICE test; Pesticide product; Regulatory process

Year:  2021        PMID: 33753176     DOI: 10.1016/j.tiv.2021.105150

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  6 in total

1.  In Vitro and In Ovo Evaluation of the Potential Hepatoprotective Effect of Metformin.

Authors:  Gabriel Veniamin Cozma; Alexandru Apostu; Ioana Macasoi; Cristina Adriana Dehelean; Octavian Marius Cretu; Stefania Dinu; Dan Gaiță; Aniko Manea
Journal:  Medicina (Kaunas)       Date:  2022-05-25       Impact factor: 2.948

2.  Phytochemical Analysis and In Vitro Cytotoxic Activity against Colorectal Adenocarcinoma Cells of Hippophae rhamnodies L., Cymbopogon citratus (D.C.) Stapf, and Ocimum basilicum L. Essential Oils.

Authors:  Alina Dolghi; Roxana Buzatu; Amadeus Dobrescu; Flavius Olaru; Grigore Alexandru Popescu; Iasmina Marcovici; Iulia Pinzaru; Dan Navolan; Octavian Marius Cretu; Iuliana Popescu; Cristina Adriana Dehelean
Journal:  Plants (Basel)       Date:  2021-12-14

3.  Methotrexate and Cetuximab-Biological Impact on Non-Tumorigenic Models: In Vitro and In Ovo Assessments.

Authors:  Andreea M Kis; Ioana Macasoi; Corina Paul; Matilda Radulescu; Roxana Buzatu; Claudia G Watz; Adelina Cheveresan; Delia Berceanu; Iulia Pinzaru; Stefania Dinu; Aniko Manea; Marioara Poenaru; Claudia Borza; Cristina A Dehelean
Journal:  Medicina (Kaunas)       Date:  2022-01-22       Impact factor: 2.430

4.  In vitro and in ovo experimental study of two anti-VEGF agents used in ophthalmology.

Authors:  Mădălina Casiana Palfi; Ovidiu Muşat; Edward Paul Şeclăman; Mihnea Munteanu; Adina Iuliana Milcu; Andreea Iordache; Alina Dolghi; Sînziana Luminiţa Istrate; Ileana Ramona Barac; Veronica Mădălina Borugă
Journal:  Rom J Morphol Embryol       Date:  2021 Jul-Sep       Impact factor: 0.833

5.  Effects of novel cellulase (Cel 906) and probiotic yeast fermentation on antioxidant and anti-inflammatory activities of vine tea (Ampelopsis grossedentata).

Authors:  Jin Xu; Mubasher Hussain; Wenfeng Su; Qian Yao; Guandong Yang; Yu Zhong; Lin Zhou; Xiaoting Huang; Zhixiang Wang; Quliang Gu; Yifei Ren; He Li
Journal:  Front Bioeng Biotechnol       Date:  2022-09-15

6.  Rutin bioconjugates as potential nutraceutical prodrugs: An in vitro and in ovo toxicological screening.

Authors:  Cristina Adriana Dehelean; Dorina Coricovac; Iulia Pinzaru; Iasmina Marcovici; Ioana Gabriela Macasoi; Alexandra Semenescu; Geza Lazar; Simona Cinta Pinzaru; Isidora Radulov; Ersilia Alexa; Octavian Cretu
Journal:  Front Pharmacol       Date:  2022-09-23       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.